Juniper Pharmaceuticals Inc (NASDAQ:JNP)

8.90
Delayed Data
As of 1:30pm ET
 +0.05 / +0.56%
Today’s Change
4.05
Today|||52-Week Range
13.25
+83.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues32.5M38.3M54.6M50.0M
 
 
 
 
 
Cost of Goods Sold15.7M19.5M22.4M26.8M
 
 
 
 
 
Depreciation And Amortization2.0M1.9M1.9M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income14.8M16.9M30.3M21.0M
 
 
 
 
 
General Expenses11.0M18.7M25.0M24.1M
 
 
 
 
 
Research And Development663.0K7.0M9.7M6.9M
 
 
 
 
 
Total Operating Expenses28.6M40.2M49.3M53.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.8M-1.9M5.3M-3.1M
 
 
 
 
 
Extraordinary Credit379.0K0.000.000.00
 
 
Extraordinary Charge--0.000.00-777.0K
 
 
Interest Expense On Debt118.0K106.0K97.0K130.0K
 
 
 
 
 
Other Expenses302.0K488.0K860.0K1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.4M-1.5M6.0M-2.2M
 
 
 
 
 
Income Taxes-988.0K-5.0K-91.0K-186.0K
 
 
 
 
 
Preferred Dividend-28.0K-28.0K-28.0K-14.0K
 
 
 
 
 
Net Income3.4M-1.5M6.0M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.0M10.8M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted11.0M10.8M10.9M10.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.27-$0.14$0.55-$0.15
 
 
 
 
 
EPS Diluted$0.27-$0.14$0.55-$0.15